While NOD2 variants are known to impair bacterial clearance and disrupt NF-κB activation (13, 29, 38, 39), paradoxically, the gut mucosa of patients with IBD often shows heightened NF-κB activity (40–44). Here, NFKB1 is linked to inflammatory bowel disease.